Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Health Technology Assessment (Winchester, England)|June 30, 2015
High-sensitivity troponin assays for the early rule-out or diagnosis of acute myocardial infarction in people with acute chest pain: a systematic review and cost-effectiveness analysisMarie Westwood, Thea van Asselt, Bram Ramaekers, et al.
Health Technology Assessment (Winchester, England)|October 15, 2014
KRAS mutation testing of tumours in adults with metastatic colorectal cancer: a systematic review and cost-effectiveness analysisMarie Westwood, Thea van Asselt, Bram Ramaekers, et al.
Urology|May 24, 2021
SpaceOAR Hydrogel Spacer for Reducing Radiation Toxicity During Radiotherapy for Prostate Cancer. A Systematic ReviewNigel Armstrong, Amit Bahl, Michael Pinkawa, et al.
Health Technology Assessment (Winchester, England)|March 3, 2016
Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluationRob Riemsma, Isaac Corro Ramos, Richard Birnie, et al.
Pharmacoeconomics|August 29, 2015
Lenalidomide for the Treatment of Low- or Intermediate-1-Risk Myelodysplastic Syndromes Associated with Deletion 5q Cytogenetic Abnormality: An Evidence Review of the NICE Submission from CelgeneHedwig M Blommestein, Nigel Armstrong, Steve Ryder, et al.
Pharmacoeconomics|March 23, 2023
Abemaciclib in Combination with Endocrine Therapy for Adjuvant Treatment of Hormone Receptor-Positive, HER2-Negative, Node-Positive Early Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology AppraisalGiovany Orozco Leal, Nigel Armstrong, Ashleigh Kernohan, et al.
Pharmacoeconomics|June 29, 2017
Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology AppraisalNasuh C Büyükkaramikli, Hedwig M Blommestein, Rob Riemsma, et al.
Pharmacoeconomics|February 27, 2018
Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology AppraisalBram L T Ramaekers, Robert F Wolff, Xavier Pouwels, et al.
Pharmacoeconomics|August 27, 2021
Filgotinib for Moderate to Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology AppraisalSabine E Grimm, Ben Wijnen, Rob Riemsma, et al.
Pharmacoeconomics|August 28, 2016
Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of an NICE Single Technology AppraisalBram L T Ramaekers, Rob Riemsma, Florian Tomini, et al.
Pageof 6